Vaccines and infectious diseases

Velocity is a leader in high-volume vaccine trials and research programs that require access to hard-to-reach patients

Most the world’s leading Sponsors and CROs have made Velocity a strategic partner for their infectious disease research programs. Velocity provides a broad global footprint to support rapid enrollment, even for studies involving sensitive cohorts (e.g., seniors, children, pregnant women, at-risk populations).

Several of Velocity’s principal investigators are also sought after by Sponsors and CROs to guide vaccine-related protocol development. These investigators have had research published in prestigious industry journals, including the New England Journal of Medicine and Vaccine.

Vaccine clinical trials conducted
Investigators supporting vaccine studies
Participants enrolled into vaccine trials

Therapeutic expertise

  • Anthrax
  • Avian Influenza
  • C. difficile (C-diff)
  • Celiac Disease
  • Chikungunya
  • Cytomegalovirus (CMV)
  • Dengue fever
  • Diphtheria
  • Ebola
  • Encephalitis
  • HCMV
  • Hepatitis B
  • Herpes
  • Human metapneumovirus (hMPV)
  • Human papillomavirus (HPV)
  • Influenza – H1N1, H5N1, H7N1, and H7N9
  • Lyme disease
  • Meningococcal
  • mRNA vaccines
  • Norovirus
  • Parainfluenza
  • Pediatric influenza
  • Pediatric meningitis
  • Pertussis
  • Plague
  • Pneumococcal
  • Rabies
  • Respiratory syncytial virus (RSV), including maternal and pediatric
  • SARS-CoV-2 (COVID-19)
  • Smallpox
  • Tetanus
  • Type 3 (PIV3)/RSV combo
  • West Nile virus
  • Zika virus
  • Zoster

The proven site network for novel vaccine research programs

Across any indication, including anti-infectives and immunologics, Velocity is prepared to support your research program for a novel vaccine, diagnostic, or combination product.

In-house monitoring, quality assurance, and audit support

PBMC processing capabilities and central laboratory support

Government-funded, Phase 1, and first-in-human trial experience

2020 Vaccine Industry Excellence (ViE) award winner for Best Clinical Trial Site, Best Clinical Trial Network

Let's talk about your next trial